Programmatic Management of Drug-resistant TB (PMDT): While the causes of multi-drug resistant TB are similar in all high burden countries
(low adherence, weak DOTS, poor treatment compliance, inadequate drug supplies, direct transmission, etc.).

Best Practices in DR-TB Community Care: Development of National Community-Based DR-TB Plans

Workshop on September 11-13, 2017 in Pretoria, South Africa

The “Best Practices in DR-TB Community Care: Development of National Community-Based DR-TB Care Plans” workshop was held in Pretoria, South Africa on the 11 - 13 September 2017, as part of the USAID-funded TB CARE II project, managed by URC. This workshop presented current best practices in drug-resistant tuberculosis (DR-TB) community care and support, with the goal of developing national roll-out plans for each of the 10 National Action Plan priority countries.

Country Program: 

FAST National Guidelines - Vietnam

The FAST strategy is mainly implemented at specialized and general hospitals with TB units. With support from the USAID TB CARE II Project, the Vietnam NTP developed the “Guideline for FAST strategy implementation”. According to the Guideline, implementing facilities should immediately order GeneXpert MTB/RIF tests for eligible patients including: Pulmonary TB patients AFB(+), presumptive drug-resistant TB patients, presumptive TB among HIV positive people, children with presumptive TB or TB meningitis.

XDR-TB Treatment: Tumpa's Story



Tumpa, a 14 year old high school student, was diagnosed with TB on March 27, 2011. Although she started taking TB medication the day after, she experienced treatment failure after three months of treatment and was diagnosed with Multi Drug Resistance Tuberculosis (MDR-TB). With her new diagnosis, Tumpa started to take her medication for MDR-TB in August of that year. However, after completing 16 months of treatment, her sputum culture and follow up result remained positive. She was then diagnosed with extensively drug-resistant TB (XDR-TB) in November 2012.

News Source: 
A N M Al Imran, University Research Co., LLC
Country Program: 

Multi-Drug Resistant TB

In 2014, approximately 480,000 people developed MDR-TB.  3.3% of new cases and 20% of previously treated patients develop MDR-TB.  It was estimated that only 41% of cases were notified that they had MDR-TB in 2014.  In low and middle income countries, access to quality TB services is often limited.  Since the beginning of TB CARE II in 2010, TB CARE II has worked to decrease MDR-TB.

TB CARE II DR TB Training Course Highlighted by CDC


In July 2014, CDC’s Find TB Resources named Adherence to MDR-TB Treatment: The 5 A’s of Patient Support, an online course developed by the DR-TB Training Network, as its Highlight of the Month (  This online course discusses key principles and steps to facilitate treatment adherence for patients with MDR-TB. The five A's presented in the course are: assess, advise, agree, arrange, and assist.



TB CARE II is excited to announce that it will be expanding its field support presence into South Africa for FY2015.  TB CARE II will build on the activities and approaches utilized by the USAID TB Program South Africa, also implemented by University Research Co., LLC (URC), which from 2009-2014 has supported the National Department of Health (NDOH) in improving early case detection, increasing access to diagnostics, ensuring treatment support for patients on TB treatment and ensuring that there is provision of appropriate and timely HIV care for TB patients and ART treatment for all TB/HIV

TB CARE II Bangladesh Celebrates Its Grantees in New Spotlight


As a component of the project, TB CARE II Bangladesh supports nongovernmental, community based organizations (NGOs) in urban and rural areas with TB case notification rates below the national average to increase detection and management of TB and MDR TB services
and to improve community knowledge and awareness of TB and MDR TB. The geographic coverage varied under different waves of grants as indicated in the table below.Since April 2012, TB CARE II has supported 11 grantees for periods of one-to-two years each.